| Darunavir intermediate | |||||
| No. | Product Name | CAS NO. | Molecular formula | Structural formula | Quality standard |
| 1 | 4-Nitrobenzenesulfonyl chloride | 98-74-8 | C6H4ClNO4S |
|
Enterprise standard |
| 2 | (3S)-tert-Butyl (4-chloro-3-oxo-1-phenylbutan-2-yl)carbamate | 102123-74-0 | C15H20ClNO3 |
|
Enterprise standard |
| Adagrasib intermediate | |||||
| No. | Product Name | CAS NO. | Molecular formula | Structural formula | Quality standard |
| 1 | (R)-1-Boc-3-hydroxymethyl-piperazine | 278788-66-2 | C10H20N2O3 |
|
Enterprise standard |
| Isavuconazole intermediate | |||||
| No. | Product Name | CAS NO. | Molecular formula | Structural formula | Quality standard |
| 1 | 4-(2-Bromoacetyl)benzonitrile | 20099-89-2 | C9H6BrNO |
|
Enterprise standard |
| 2 | alpha-Chloro-4'-cyanoacetophenone | 40805-50-3 | C9H6ClNO |
|
Enterprise standard |
| Vonapraza intermediate | |||||
| No. | Product Name | CAS NO. | Molecular formula | Structural formula | Quality standard |
| 1 | 2-Bromo-2'-fluoroacetophenone | 655-15-2 | C8H6BrFO |
|
Enterprise standard |
| 2 | 2-Chloro-1-(2-fluorophenyl)ethan-1-one | 53688-17-8 | C8H6ClFO |
|
Enterprise standard |
| 3 | pyridine-3-sulfonyl chloride | 16133-25-8 | C5H4ClNO2S |
|
Enterprise standard |
| 4 | 5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde | 881674-56-2 | C11H8FNO |
|
Enterprise standard |
| 5 | 5-(2-Fluorophenyl)-1-[(pyridin-3-yl)sulfonyl]-1H-pyrrole-3-carboxaldehyde | 881677-11-8 | C16H11FN2O3S |
|
Enterprise standard |
| Upadacitinib intermediate | |||||
| No. | Product Name | CAS NO. | Molecular formula | Structural formula | Quality standard |
| 1 | (3R,4S)-1-((benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid | 1428243-24-6 | C15H19NO4 |
|
Enterprise standard |
| 2 | (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester | 1428243-26-8 | C16H20BrNO3 |
|
Enterprise standard |
| Abiraterone intermediate | |||||
| No. | Product Name | CAS NO. | Molecular formula | Structural formula | Quality standard |
| 1 | 3-Pyridyl bromide | 626-55-1 | C5H4BrN |
|
Enterprise standard |
| 2 | Diethyl(3-pyridyl)borane | 89878-14-8 | C9H14BN |
|
Enterprise standard |
| Torasemide intermediate | |||||
| No. | Product Name | CAS NO. | Molecular formula | Structural formula | Quality standard |
| 1 | 4-(3'-Methylphenyl)amino-3-pyridinesulfonamide | 72811-73-5 | C12H13N3O2S |
|
Enterprise standard |
| 2 | 4-Hydroxypyridine-3-sulfonic acid | 51498-37-4 | C5H5NO4S |
|
Enterprise standard |
| Paxlovid intermediate | |||||
| No. | Product Name | CAS NO. | Molecular formula | Structural formula | Quality standard |
| 1 | 6,6-Dimethyl-3-azabicyclo[3.1.0]hexane | 943516-54-9 | C7H13N |
|
Enterprise standard |
| Flame retardants intermediate | |||||
| No. | Product Name | CAS NO. | Molecular formula | Structural formula | Quality standard |
| 1 | 10-(2,5-Dihydroxyphenyl)-10H-9-oxa-10-phospha-phenantbrene-10-oxide | 99208-50-1 | C18H13O4P |
|
Enterprise standard |
| Raw materials of Aesthetic medicine | |||||
| No. | Product Name | CAS NO. | Molecular formula | Structural formula | Quality standard |
| 1 | 3-O-Ethyl-L-ascorbic acid | 86404-04-8 | C8H12O6 |
|
Enterprise standard |
| API | |||||
| No. | Product Name | CAS NO. | Molecular formula | Structural formula | Quality standard |
| 1 | palonosetron hydrochloride | 135729-62-3 | C19H24N2O HCl |
|
Enterprise standard |

.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
![5-(2-Fluorophenyl)-1-[(pyridin-3-yl)sulfonyl]-1H-pyrrole-3-carboxaldehyde](/Uploads/fzs(31).png)
.png)
.png)
.png)
.png)
.png)
.png)
![6,6-Dimethyl-3-azabicyclo[3.1.0]hexane](/Uploads/fzs(45).png)
.png)
.png)
.png)
.png)
.png)
.png)
![(2R)-rel-6-Fluoro-3,4-dihydro-2-[(2S)-2-oxiranyl]-2H-1-benzopyran](/Uploads/fzs(54).png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
